Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP498414.RA4o_WZQ4w_llx7TRulmiDKB-l5tr03muN_OxDjaHvfv4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP498414.RA4o_WZQ4w_llx7TRulmiDKB-l5tr03muN_OxDjaHvfv4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP498414.RA4o_WZQ4w_llx7TRulmiDKB-l5tr03muN_OxDjaHvfv4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP498414.RA4o_WZQ4w_llx7TRulmiDKB-l5tr03muN_OxDjaHvfv4130_provenance.
- NP498414.RA4o_WZQ4w_llx7TRulmiDKB-l5tr03muN_OxDjaHvfv4130_assertion description "[The CD14 CC genotype was associated with incidence of new coronary occlusion (P=0.026); TNF-alpha AA genotype with history of myocardial infarction (MI, P=0.04), and A allele with total occlusions at baseline (P=0.027), and systolic blood pressure (P=0.046); and IL-6-174 CC genotype with baseline minimum lumen diameter (P=0.043) and reduction in lipoprotein(a) with fluvastatin (P=0.03).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP498414.RA4o_WZQ4w_llx7TRulmiDKB-l5tr03muN_OxDjaHvfv4130_provenance.
- NP498414.RA4o_WZQ4w_llx7TRulmiDKB-l5tr03muN_OxDjaHvfv4130_assertion evidence source_evidence_literature NP498414.RA4o_WZQ4w_llx7TRulmiDKB-l5tr03muN_OxDjaHvfv4130_provenance.
- NP498414.RA4o_WZQ4w_llx7TRulmiDKB-l5tr03muN_OxDjaHvfv4130_assertion SIO_000772 11199329 NP498414.RA4o_WZQ4w_llx7TRulmiDKB-l5tr03muN_OxDjaHvfv4130_provenance.
- NP498414.RA4o_WZQ4w_llx7TRulmiDKB-l5tr03muN_OxDjaHvfv4130_assertion wasDerivedFrom befree-20150227 NP498414.RA4o_WZQ4w_llx7TRulmiDKB-l5tr03muN_OxDjaHvfv4130_provenance.
- NP498414.RA4o_WZQ4w_llx7TRulmiDKB-l5tr03muN_OxDjaHvfv4130_assertion wasGeneratedBy ECO_0000203 NP498414.RA4o_WZQ4w_llx7TRulmiDKB-l5tr03muN_OxDjaHvfv4130_provenance.
- befree-20150227 importedOn "2015-02-27" NP498414.RA4o_WZQ4w_llx7TRulmiDKB-l5tr03muN_OxDjaHvfv4130_provenance.